Tat-ENAEYLR

General Information


DRACP ID  DRACP05708

Peptide Name   Tat-ENAEYLR

Sequence  YGRKKRRQRRRENAEYLR

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X=acp, Epsilon-aminocaproic acid

Chiral  L



Physicochemical Information


Formula  C102H175N43O27

Absent amino acids  CDFHIMPSTVW

Common amino acids  R

Mass  273916

Pl  12.13

Basic residues  9

Acidic residues  2

Hydrophobic residues  2

Net charge  7

Boman Index  -13395

Hydrophobicity  -281.67

Aliphatic Index  27.22

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  2980

Absorbance 280nm  175.29

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23085023

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2767

DRACP is developed by Dr.Zheng's team.